IOVA icon

Iovance Biotherapeutics

294 hedge funds and large institutions have $1.86B invested in Iovance Biotherapeutics in 2024 Q2 according to their latest regulatory filings, with 67 funds opening new positions, 114 increasing their positions, 80 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding:

5.32% more ownership

Funds ownership: 77.77%83.09% (+5.3%)

38% less funds holding in top 10

Funds holding in top 10: 85 (-3)

42% less capital invested

Capital invested by funds: $3.22B → $1.86B (-$1.35B)

Holders
294
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$25.3M
Puts
$18.5M
Net Calls
Net Calls Change

Top Sellers

1 -$22M
2 -$18.7M
3 -$14.3M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$13.6M
5
Millennium Management
Millennium Management
New York
-$11.6M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$1,000K
102
$942K
103
$922K
104
$914K
105
$912K
106
$902K
107
$900K
108
$799K
109
$797K
110
$755K
111
$736K
112
$731K
113
$679K
114
$661K
115
$641K
116
$632K
117
$619K
118
$611K
119
$598K
120
$587K
121
$582K
122
$574K
123
$573K
124
$569K
125
$525K